Aspen Targets Mounjaro Expansion in Africa Following Approval

Aspen's Mounjaro expansion plans promise to enhance diabetes and weight management treatment in Sub-Saharan Africa soon.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Tagged Aspen Pharmacare, diabetes, Eli Lilly, Healthcare Business, mounjaro, pharmaceuticals, SAHPRA, Stephen Saad, Sub-Saharan Africa, Tirzepatide, weight-loss drugs